KAYA HOLDINGS, INC.

KAYS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2015 FY2014
Revenue $323.9K $74.5K
Cost of Revenue $144.6K $49.0K
Gross Profit $179.4K $25.5K
Gross Margin 55.4% 34.2%
Operating Expenses
Research & Development
SG&A Expense $1.6M $1.1M
Operating Income $-1.5M $-1.1M
Operating Margin -466.2% -1,431.8%
Interest Expense $163.9K $24.0K
Pretax Income
Income Tax Expense
Net Income $-3.2M $-2.5M
Net Margin -995.7% -3,403.7%
EPS (Basic) $-0.04 $-0.03
EPS (Diluted) $-0.04 $-0.03
Shares Outstanding (Basic) 88.9M 76.3M
Shares Outstanding (Diluted) 88.9M 76.3M
Dividends Per Share
← Newer Page 2 of 2 Older →